Atlas Trials

Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser

Clinical trial NCT01578421 · COMPLETED

Trial details

NCT number
NCT01578421
Sponsor
Kantonsspital Aarau
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Renal Failure Chronic Requiring Hemodialysis
Start date
2012-02-01
Primary completion
2012-09-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.